News

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...
Interestingly, weight loss is a known side effect of this medication, and that’s what has sparked interest beyond the ...
Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.
Manhattanites are flocking to restaurants that are being compared to Applebee's and TGI Friday's in search of simple meals - ...
Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...
Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.
CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at ...